uu.seUppsala universitets publikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Advances in stem cell therapy for amyotrophic lateral sclerosis
Maggiore Carita Univ Hosp Novara, Dept Neurol, ALS Ctr, Novara, Italy.
Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.
Univ Belgrade, Fac Biol, Ctr Laser Microscopy, Belgrade, Serbia.
Polish Acad Sci, Mossakowski Med Res Ctr, Stem Cell Bioengn Unit, Warsaw, Poland.
Visa övriga samt affilieringar
2018 (Engelska)Ingår i: Expert Opinion on Biological Therapy, ISSN 1471-2598, E-ISSN 1744-7682, Vol. 18, nr 8, s. 865-881Artikel, forskningsöversikt (Refereegranskat) Published
Abstract [en]

Introduction: Amyotrophic Lateral Sclerosis (ALS) is a progressive, incurable neurodegenerative disease that targets motoneurons. Cell-based therapies have generated widespread interest as a potential therapeutic approach but no conclusive results have yet been reported either from pre-clinical or clinical studies. Areas covered: This is an integrated review of pre-clinical and clinical studies focused on the development of cell-based therapies for ALS. We analyze the biology of stem cell treatments and results obtained from pre-clinical models of ALS and examine the methods and the results obtained to date from clinical trials. We discuss scientific, clinical, and ethical issues and propose some directions for future studies. Expert opinion: While data from individual studies are encouraging, stem-cell-based therapies do not yet represent a satisfactory, reliable clinical option. The field will critically benefit from the introduction of well-designed, randomized and reproducible, powered clinical trials. Comparative studies addressing key issues such as the nature, properties, and number of donor cells, the delivery mode and the selection of proper patient populations that may benefit the most from cell-based therapies are now of the essence. Multidisciplinary networks of experts should be established to empower effective translation of research into the clinic.

Ort, förlag, år, upplaga, sidor
2018. Vol. 18, nr 8, s. 865-881
Nyckelord [en]
Amyotrophic lateral sclerosis, stem cells, transplantation, clinical trials, animal models, cellular models
Nationell ämneskategori
Cell- och molekylärbiologi Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)
Identifikatorer
URN: urn:nbn:se:uu:diva-366394DOI: 10.1080/14712598.2018.1503248ISI: 000445196000004PubMedID: 30025485OAI: oai:DiVA.org:uu-366394DiVA, id: diva2:1265126
Tillgänglig från: 2018-11-22 Skapad: 2018-11-22 Senast uppdaterad: 2018-11-22Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMed

Personposter BETA

Kozlova, Elena

Sök vidare i DiVA

Av författaren/redaktören
Kozlova, Elena
Av organisationen
Regenerativ neurobiologi
I samma tidskrift
Expert Opinion on Biological Therapy
Cell- och molekylärbiologiMedicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 138 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf